Overview

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if bacterial load in the airways can be reduced after inhalation of ciprofloxacin for 28 days.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Collaborator:
Novartis
Treatments:
Ciprofloxacin